ArticleNPJ precision oncology2024
DDR1 is identified as an immunotherapy target for microsatellite stable colon cancer by CRISPR screening.
Miaoqing Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it